Target intelligence / Profile preview

Reactive carbonyl compound (AGE carbonyl precursor) (RCC (occasionally used, but not universal))

Target
RCC (occasionally used, but not universal)
Molecular classification
Other (Small molecule; Metabolite)
01

Overview

Reactive carbonyl compound (AGE carbonyl precursor) refers to a chemically heterogeneous group of small, highly reactive carbonyl-containing metabolites, particularly dicarbonyls such as glyoxal, methylglyoxal, and 3-deoxyglucosone. These compounds are generated during normal metabolism (e.g., glycolysis, lipid peroxidation) and dramatically increase in states of oxidative stress or hyperglycemia. They nonenzymatically react with amino groups on proteins, nucleic acids, and other macromolecules to form advanced glycation end-products (AGEs), a process implicated in vascular, renal, neurodegenerative, and aging-related diseases. While not classical drug targets, pharmacological and dietary interventions have focused on trapping or reducing these reactive carbonyls to prevent AGE formation and downstream tissue damage[1][3][5][7][8].

Other names
Reactive carbonylsReactive carbonyl species (RCS)Dicarbonyls (e.g., methylglyoxal, glyoxal, 3-deoxyglucosone)AGE precursor(s)
02

Mechanism of action

Drugs that trap reactive carbonyls neutralize them before they react with proteins Some drugs inhibit the metabolic pathways that generate these dicarbonyls (antioxidants, glyoxalase modulators)

03

Biological functions

Serve as intermediates in non-enzymatic protein glycation (Maillard reaction)Promote formation of AGEs via reaction with amino groups on proteins, nucleic acids, and lipids
04

Disease associations

Diabetes complications (especially nephropathy and vascular complications)Cardiovascular diseaseNeurodegenerative disease (Alzheimer's, Parkinson's disease)Aging and age-related tissue damage
05

Safety considerations

Off-target effects possible with drugs that scavenge reactive carbonyls (e.g., amines like aminoguanidine may have other reactivity/toxicity)Some drugs targeting carbonyl stress have failed due to safety/toxicity concerns (e.g., aminoguanidine in clinical trials)
06

Interacting drugs

Aminoguanidine (traps dicarbonyls, prevents AGE formation)

3 more in the full profile.

07

Biomarkers

Plasma concentration of methylglyoxal, glyoxal, and 3-deoxyglucosone are used as surrogate biomarkers to estimate AGE precursor loadPentosidine—an AGE whose levels correlate with precursor abundance

Beyond the preview

Go deeper on Reactive carbonyl compound (AGE carbonyl precursor) (RCC (occasionally used, but not universal)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive carbonyl compound (AGE carbonyl precursor) (RCC (occasionally used, but not universal)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call